This case report details spinal anaesthesia for an elective caesarean section in a patient with the rare condition of paramyotonia congenita. There are few case reports of anaesthesia in this condition and none in the Australian anaesthetic literature. This case highlights the need for the avoidance of hypothermia and depolarizing muscle relaxants, the safety of spinal anaesthesia and a conservative approach to the management of plasma potassium concentration. The subsequent review outlines the current literature and discusses other issues involved in the anaesthetic management of this disorder.
Paramyotonia congenita (PMC) is a rare muscle condition originally known as Eulenberg's disease after its description by Eulenberg in Germany in 1886 1 . It is inherited in an autosomal dominant fashion. There are ongoing controversies regarding the classification of PMC, particularly in relation to the periodic paralyses 2 . PMC represents one of three major variants of hyperkalaemic periodic paralysis, i.e. hyperkalaemic periodic paralysis with myotonia, hyperkalaemic periodic paralysis without myotonia and hyperkalaemic periodic paralysis with paramyotonia 2 . However it would seem that this is an oversimplification of what is likely to be a large number of disorders now known to be associated with abnormalities in the sodium channel of the muscle membrane 3 . This would, in part, account for the difficulty encountered in the classification of these disorders. PMC is distinct from myotonia congenita and myotonic dystrophy.
PMC is characterized by cold-induced myotonia, (failure of muscle relaxation), followed by flaccid paresis, and in contrast to the other more commonly known myotonias, the myotonia is worsened by exercise rather than alleviated by it. This latter phenomenon is known as "paradoxical myotonia". Percussion myotonia is not consistently associated with PMC 4 , which is a non-progressive disorder. In keeping with the other variants of hyperkalaemic periodic paralysis, PMC may show disturbances in potassium handling with both hypo-and hyperkalaemia being reported. This further adds to the confusion surrounding the nosological classification of this disease 5, 6 . Oral potassium challenge with between 5 and 10 g of potassium has been used as a diagnostic aid to produce myotonia, but this is unlikely to be reliable 7 . There may be mild muscle hypertrophy but otherwise PMC appears devoid of lesions commonly associated with other myopathies, such as cardiac, neuropsychiatric or ophthalmological abnormalities.
The genetic defect in PMC maps to the same gene locus on chromosome 17 as the other hyperkalaemic periodic paralyses, lending further credence to its grouping with this disorder. The primary abnormality is thought to be a point mutation at the level of the α-subunits in the sodium channel of the muscle membrane 8 . This is in contrast to the chloride channel abnormalities found in myotonia congenita. More than 15 separate mutations have been identified in association with abnormal sodium channels 8 in these disorders. In cold conditions the abnormal sodium channels are thought to enter an inactivated state from which they may readily reopen. This leads to an inward sodium current, depolarization of the muscle membrane and further inactivation of other sodium channels 9 .
Numerous drug therapies have been tried, with varying success, to control the myotonia. The current recommendation is that avoidance of precipitants represents the best treatment option. If this is inadequate, trials of procainamide, tocainide, mexiletine or other class Ia anti-arrhythmics may be warranted.
CASE HISTORY
A 29-year old woman presented for elective caesarean section at 39 weeks. In addition to PMC she had, as a child, suffered from bilateral Perthe's disease of the hips. This had resulted in minimal hip mobility, notably fixed flexion and limited abduction. There were concerns about the safety of vaginal delivery and consequently an elective caesarean section was planned. The patient had a family history of PMC and gave a classic description of myotonia on exposure to cold, e.g., on trips to the snowfields, on entering cold water, difficulty moving on cold mornings or when eating very cold foods. These episodes could last several hours and be incapacitating. She also listed an aversion to foodstuffs high in potassium. She provided a copy of a letter detailing the rapid onset of flaccid quadraparesis in her mother when aged 35, following an epidural block for a gynaecological procedure. At that time her mother was said to have had an "absence of deep tendon reflexes" and "bilateral Babinski signs". The serum potassium four days after the onset of paresis was reported as 6 mEq/l. She did not require ventilation and was treated with intravenous dextrose and diuretics. This paresis lasted several days. Her mother was discharged after seven days having "almost completely recovered". The diagnosis at the time was "hereditary episodical adynamia" (now known as hyperkalaemic periodic paralysis). This was later revised to PMC.
Our patient was fasted and following sodium citrate premedication was brought to the theatre fully clothed. Her preoperative potassium concentration was 3.8 mmol/l. The operating room had been prewarmed to 24°C. All intravenous and skin sterilization fluids were also warmed. Following venous cannulation and 500 ml of warmed normal saline, 2.2 ml of 0.5% plain bupivacaine with 20 µg fentanyl citrate were introduced into the subarachnoid space via a 27 gauge spinal needle at the L3/4 interspace. Ephedrine sulphate 9 mg was added to the 500 ml of normal saline.
Blood pressure and pulse measurements remained stable following administration of the spinal block. The patient at no time complained of symptoms suggesting hypothermia and temperature recordings remained at 36.9 to 37.2°C at all times. After determining an adequate block by forceps skin pinch testing, an uneventful caesarean section was performed with delivery of a healthy infant. The patient went to the recovery ward where a hot-air blanket was used to ensure thermal comfort. Postoperative analgesia was provided by 48 hours of regular diclofenac sodium suppositories, paracetamol and intravenous morphine via a patient-controlled analgesia device. Her recovery and that of the baby was uneventful. She was discharged home on postoperative day five.
DISCUSSION
There are few case reports of anaesthesia in PMC. In much of the literature the myotonias are poorly classified and this leads to confusion. Reece et al 10 reported a case of a patient with PMC undergoing hypothermic cardiopulmonary bypass. Their patient underwent controlled hypothermia to 28°C. They paid strict attention to adequate rewarming, anticipated potassium losses, avoided depolarizing muscle relaxants and halothane and the patient had an uneventful recovery. Chitayat et al 11 reported the case of cold-induced abortion in a patient with paramyotonia congenita, stressing the importance of good thermal control in the pregnant patient with PMC. Howell and Douglas 12 reported a case of a parturient with both lupus anticoagulant and PMC (with PMC thought to have been a contributing factor to at least one fetal loss). This patient had epidural analgesia during labour on two occasions without problem. Ashwood et al described successful general anaesthetics in four members of one family with PMC 2 . Previous difficulties with suxamethonium were described in nearly all of their cases. They used and advocated preoperative frusemide for its kaliuretic effect in addition to warming and avoidance of depolarizing muscle relaxants. It is important to note that in all their cases nondepolarizing agents were used without problem. Bermejo et al 13 Neither Howell, Bermejo or Arcas administered preoperative kaliuretics. Indeed the case for preoperative potassium manipulation is unclear. There are case reports with and without preoperative potassium manipulation, both approaches appearing successful. Our preference was to leave potassium regulation under endogenous control, particularly as diagnostic evidence for the impact of changes in serum potassium on the individual patient's myotonia may be unavailable or unreliable 7 . This patient, despite listing an aversion to potassium containing foods, had never had a potassium challenge, never taken kaliuretics and had a normal preoperative potassium level.
Intraoperatively both central neuraxis (spinal and epidural) and general anaesthesia have been used successfully. If shivering should occur, this should be treated with a small dose of intravenous pethidine or clonidine 15, 16 . The efficacy of central neuraxis blockade should not be checked with ice as this may precipitate myotonia. In our case spinal anaesthesia was chosen because it has been shown to be safe and its quick insertion and onset helps to minimize operating theatre time. The shivering threshold for spinal and epidural anaesthesia is nearly identical, thus not influencing the choice between spinal or epidural anaesthesia 17, 18 .
Suxamethonium and other depolarizing agents should be avoided due to the risk of inducing myotonia. However there is no evidence to suggest these patients are more sensitive to the nondepolarizing muscle relaxants and if rapid endotracheal intubation were required, rocuronium bromide would likely be the relaxant of choice.
Some authors have advocated avoiding halothane due to its propensity to cause postoperative shivering 19 and the fact that this may result in a myotonic episode. However postoperative shivering is a feature of nearly all volatile anaesthetics.
The physiological disturbance in PMC is an abnormality in sodium conductance, not the control of calcium. Therefore, these patients should not be susceptible to malignant hyperthermia. Lehmann-Horn investigated this issue, reaching the same conclusion 20 . Some of these patients will, however, display a raised creatinine kinase on routine blood testing 4 .
Subcutaneous neostigmine 1.5 mg has been reported to cause myotonia 4 . In the context of anaesthesia, the use of normal reversal doses of neostigmine has not been reported to cause problems.
Numerous agents have been suggested for prevention or management of a myotonic episode. These include the use of type I anti-arrhythmics such as procainamide, tocainide, mexiletine and quinidine, as well as other agents including adrenaline, acetazolamide, salbutamol and calcium gluconate [21] [22] [23] [24] [25] . The management of a myotonic crisis should include urgent measurement of the serum potassium (with manoeuvres to correct this towards normal), ensuring the patient is sufficiently warm, minimizing muscle stimulation and then perhaps trialing one of the type I anti-arrhythmics such as procainamide. There are no reports of PMC patients requiring ventilation after developing flaccid paresis, although admission to intensive care postoperatively in the event of a crisis would seem prudent. Postoperatively ongoing attention to thermal comfort is important. Opioid analgesics and non-steroidal analgesics are tolerated normally.
In summary, the understanding of the physiological basis of PMC is advancing rapidly. PMC is a variant of hyperkalaemic periodic paralysis clinically distinguished by sensitivity to cold and paradoxical myotonia. The management of these patients requires routine preoperative assessment, plus an assessment of their sensitivity to cold, the frequency of myotonic episodes and patient sensitivity to changes in serum potassium. Preparation should include warming of the operating environment and warming of intravenous and skin preparation fluids. The maintenance of the patient's thermal comfort during transfer is also important. Patients with PMC display normal tolerance to nondepolarizing muscle relaxants, although depolarizing agents should be avoided. Central neuraxis and general anaesthesia may be undertaken with safety, provided there is adequate attention to the maintenance of normothermia. Patients with PMC are not at increased risk of malignant hyperthermia.
